{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:19:30Z","timestamp":1790061570040,"version":"4.0.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["Discovery Grant & CRD Grant"],"award-info":[{"award-number":["Discovery Grant & CRD Grant"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a need to demonstrate a proof of principle that proteomics has the capacity to analyze plasma from breast cancer versus other diseases and controls in a multisite clinical trial design. The peptides or proteins that show a high observation frequency, and\/or precursor intensity, specific to breast cancer plasma might be discovered by comparison to other diseases and matched controls. The endogenous tryptic peptides of breast cancer plasma were compared to ovarian cancer, female normal, sepsis, heart attack, Alzheimer\u2019s and multiple sclerosis along with the institution-matched normal and control samples collected directly onto ice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Endogenous tryptic peptides were extracted from individual breast cancer and control EDTA plasma samples in a step gradient of acetonitrile, and collected over preparative C18 for LC\u2013ESI\u2013MS\/MS with a set of LTQ XL linear quadrupole ion traps working together in parallel to randomly and independently sample clinical populations. The MS\/MS spectra were fit to fully tryptic peptides or phosphopeptides within proteins using the X!TANDEM algorithm. The protein observation frequency was counted using the SEQUEST algorithm after selecting the single best charge state and peptide sequence for each MS\/MS spectra. The observation frequency was subsequently tested by Chi Square analysis. The log\n                      <jats:sub>10<\/jats:sub>\n                      precursor intensity was compared by ANOVA in the R statistical system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Peptides and\/or phosphopeptides of common plasma proteins such as APOE, C4A, C4B, C3, APOA1, APOC2, APOC4, ITIH3 and ITIH4 showed increased observation frequency and\/or precursor intensity in breast cancer. Many cellular proteins also showed large changes in frequency by Chi Square (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u2009100, p\u2009&lt;\u20090.0001) in the breast cancer samples such as CPEB1, LTBP4, HIF-1A, IGHE, RAB44, NEFM, C19orf82, SLC35B1, 1D12A, C8orf34, HIF1A, OCLN, EYA1, HLA-DRB1, LARS, PTPDC1, WWC1, ZNF562, PTMA, MGAT1, NDUFA1, NOGOC, OR1E1, OR1E2, CFI, HSA12, GCSH, ELTD1, TBX15, NR2C2, FLJ00045, PDLIM1, GALNT9, ASH2L, PPFIBP1, LRRC4B, SLCO3A1, BHMT2, CS, FAM188B2, LGALS7, SAT2, SFRS8, SLC22A12, WNT9B, SLC2A4, ZNF101, WT1, CCDC47, ERLIN1, SPFH1, EID2, THOC1, DDX47, MREG, PTPRE, EMILIN1, DKFZp779G1236 and MAP3K8 among others. The protein gene symbols with large Chi Square values were significantly enriched in proteins that showed a complex set of previously established functional and structural relationships by STRING analysis. An increase in mean precursor intensity of peptides was observed for QSER1 as well as SLC35B1, IQCJ-SCHIP1, MREG, BHMT2, LGALS7, THOC1, ANXA4, DHDDS, SAT2, PTMA and FYCO1 among others. In contrast, the QSER1 peptide QPKVKAEPPPK was apparently specific to ovarian cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There was striking agreement between the breast cancer\u00a0plasma peptides and proteins discovered by LC\u2013ESI\u2013MS\/MS with previous biomarkers from tumors, cells lines or body fluids by genetic or biochemical methods. The results indicate that variation in plasma peptides from breast cancer versus ovarian cancer may be directly discovered by LC\u2013ESI\u2013MS\/MS that will be a powerful tool for clinical research. It may be possible to use a battery of sensitive and robust linear quadrupole ion traps for random and independent sampling of plasma from a multisite clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-019-9262-0","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T03:03:38Z","timestamp":1577070218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The plasma peptides of breast versus ovarian cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Jaimie","family":"Dufresne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanusi","family":"Thavarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Florentinus-Mefailoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Tucholska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Norzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Truc","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morla","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargiz","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ravandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Romaschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Addison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren","family":"Heyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. W. M.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-1448","authenticated-orcid":false,"given":"John G.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"18","key":"9262_CR1","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/pmic.201000100","volume":"10","author":"A Tiss","year":"2010","unstructured":"Tiss A, et al. A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics. 2010;10(18):3388\u201392.","journal-title":"Proteomics"},{"issue":"16","key":"9262_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0142-9612(00)00054-5","volume":"21","author":"RD Oleschuk","year":"2000","unstructured":"Oleschuk RD, et al. Characterization of plasma proteins adsorbed onto biomaterials. By MALDI-TOFMS. Biomaterials. 2000;21(16):1701\u201310.","journal-title":"Biomaterials"},{"issue":"5","key":"9262_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0090-4295(01)01659-4","volume":"59","author":"H Tammen","year":"2002","unstructured":"Tammen H, et al. Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity\u2013an experimental approach using the novel differential peptide display technology. Urology. 2002;59(5):784\u20139.","journal-title":"Urology"},{"issue":"4","key":"9262_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1586\/14737159.2.4.312","volume":"2","author":"AM Ardekani","year":"2002","unstructured":"Ardekani AM, Liotta LA, Petricoin EF 3rd. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev Mol Diagn. 2002;2(4):312\u201320.","journal-title":"Expert Rev Mol Diagn"},{"issue":"9306","key":"9262_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","volume":"359","author":"EF Petricoin","year":"2002","unstructured":"Petricoin EF, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572\u20137.","journal-title":"Lancet"},{"issue":"1","key":"9262_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1172\/JCI26022","volume":"116","author":"J Villanueva","year":"2006","unstructured":"Villanueva J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006;116(1):271\u201384.","journal-title":"J Clin Invest"},{"issue":"10","key":"9262_CR7","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1074\/mcp.M600229-MCP200","volume":"5","author":"J Villanueva","year":"2006","unstructured":"Villanueva J, et al. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics. 2006;5(10):1840\u201352.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"9262_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1074\/mcp.M700397-MCP200","volume":"7","author":"J Villanueva","year":"2008","unstructured":"Villanueva J, et al. A sequence-specific exopeptidase activity test (SSEAT) for \u201cfunctional\u201d biomarker discovery. Mol Cell Proteomics. 2008;7(3):509\u201318.","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"9262_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1373\/clinchem.2009.133363","volume":"56","author":"JF Timms","year":"2010","unstructured":"Timms JF, et al. Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer. Clin Chem. 2010;56(2):262\u201371.","journal-title":"Clin Chem"},{"issue":"3","key":"9262_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/biostatistics\/kxp006","volume":"10","author":"JE Eckel-Passow","year":"2009","unstructured":"Eckel-Passow JE, et al. An insight into high-resolution mass-spectrometry data. Biostatistics. 2009;10(3):481\u2013500.","journal-title":"Biostatistics"},{"issue":"9","key":"9262_CR11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/pmic.200300522","volume":"3","author":"KA Baggerly","year":"2003","unstructured":"Baggerly KA, et al. A comprehensive approach to the analysis of matrix-assisted laser desorption\/ionization-time of flight proteomics spectra from serum samples. Proteomics. 2003;3(9):1667\u201372.","journal-title":"Proteomics"},{"key":"9262_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/pr030003l","volume":"2","author":"J Marshall","year":"2003","unstructured":"Marshall J, et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res. 2003;2:361\u201372.","journal-title":"J Proteome Res"},{"issue":"3","key":"9262_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1021\/pr034039p","volume":"3","author":"J Marshall","year":"2004","unstructured":"Marshall J, et al. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J Proteome Res. 2004;3(3):364\u201382.","journal-title":"J Proteome Res"},{"key":"9262_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jprot.2009.08.004","volume":"73","author":"P Bowden","year":"2009","unstructured":"Bowden P, Beavis R, Marshall J. Tandem mass spectrometry of human tryptic blood peptides calculated by a statistical algorithm and captured by a relational database with exploration by a general statistical analysis system. J Proteomics. 2009;73:103\u201311.","journal-title":"J Proteomics"},{"key":"9262_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jprot.2011.11.002","volume":"75","author":"AK Florentinus","year":"2012","unstructured":"Florentinus AK, et al. Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance. J Proteomics. 2012;75:1303\u201317.","journal-title":"J Proteomics"},{"key":"9262_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jprot.2011.08.011","volume":"75","author":"AK Florentinus","year":"2011","unstructured":"Florentinus AK, et al. The Fc receptor-cytoskeleton complex from human neutrophils. J Proteomics. 2011;75:450\u201368.","journal-title":"J Proteomics"},{"key":"9262_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12014-017-9176-7","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. Random and independent sampling of endogenous tryptic peptides from normal human EDTA plasma by liquid chromatography micro electrospray ionization and tandem mass spectrometry. Clin Proteomics. 2017;14:41.","journal-title":"Clin Proteomics"},{"key":"9262_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12014-017-9170-0","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. Freeze-dried plasma proteins are stable at room temperature for at least 1 year. Clin Proteomics. 2017;14:35.","journal-title":"Clin Proteomics"},{"key":"9262_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12014-017-9174-9","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. The proteins cleaved by endogenous tryptic proteases in normal EDTA plasma by C18 collection of peptides for liquid chromatography micro electrospray ionization and tandem mass spectrometry. Clin Proteomics. 2017;14:39.","journal-title":"Clin Proteomics"},{"issue":"5","key":"9262_CR20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mas.20291","volume":"30","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Mass spectrometry of peptides and proteins from human blood. Mass Spectrom Rev. 2011;30(5):685\u2013732.","journal-title":"Mass Spectrom Rev"},{"key":"9262_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ab.2018.02.025","volume":"549","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. A method for the extraction of the endogenous tryptic peptides (peptidome) from human EDTA plasma. Anal Biochem. 2018;549:188\u201396.","journal-title":"Anal Biochem"},{"key":"9262_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1021\/pr8005217","volume":"8","author":"M Tucholska","year":"2009","unstructured":"Tucholska M, et al. Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS\/MS. J Proteome Res. 2009;8:1143\u201355.","journal-title":"J Proteome Res"},{"key":"9262_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ab.2007.07.029","volume":"370","author":"M Tucholska","year":"2007","unstructured":"Tucholska M, et al. Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption\/ionization and electrospray ionization hybrid quadrupole time-of-flight. Anal Biochem. 2007;370:228\u201345.","journal-title":"Anal Biochem"},{"issue":"1","key":"9262_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1385\/CP:2:1:67","volume":"2","author":"D Williams","year":"2006","unstructured":"Williams D, Zhu P, Bowden P, Stacey C, McDonell M, Kowalski P, Kowalski JM, Evans K, Diamandis EP, Siu KM, Marshall J. Comparison of methods to examine the endogenous peptides of fetal calf serum. Clin Proteomics. 2006;2(1):67.","journal-title":"Clin Proteomics"},{"issue":"6","key":"9262_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jprot.2010.02.022","volume":"73","author":"M Tucholska","year":"2010","unstructured":"Tucholska M, et al. The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF. J Proteomics. 2010;73(6):1254\u201369.","journal-title":"J Proteomics"},{"key":"9262_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00216-009-3345-0","volume":"396","author":"D Williams","year":"2010","unstructured":"Williams D, et al. Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides. Anal Bioanal Chem. 2010;396:1223\u201347.","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"9262_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/pmic.200300677","volume":"4","author":"O Chertov","year":"2004","unstructured":"Chertov O, et al. Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics. 2004;4(4):1195\u2013203.","journal-title":"Proteomics"},{"issue":"10","key":"9262_CR28","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","volume":"2","author":"RS Tirumalai","year":"2003","unstructured":"Tirumalai RS, et al. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003;2(10):1096\u2013103.","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"9262_CR29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/pmic.200300449","volume":"3","author":"R Pieper","year":"2003","unstructured":"Pieper R, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics. 2003;3(7):1345\u201364.","journal-title":"Proteomics"},{"issue":"3","key":"9262_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nbt0303-221","volume":"21","author":"SD Patterson","year":"2003","unstructured":"Patterson SD. Data analysis-the Achilles heel of proteomics. Nat Biotechnol. 2003;21(3):221\u20132.","journal-title":"Nat Biotechnol"},{"key":"9262_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ab.2018.08.025","volume":"560","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. Re-evaluation of the rabbit myosin protein standard used to create the empirical statistical model for decoy library searching. Anal Biochem. 2018;560:39\u201349.","journal-title":"Anal Biochem"},{"key":"9262_CR32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/pr2000013","volume":"11","author":"P Bowden","year":"2012","unstructured":"Bowden P, et al. Quantitative statistical analysis of standard and human blood proteins from liquid chromatography, electrospray ionization, and tandem mass spectrometry. J Proteome Res. 2012;11:2032\u201347.","journal-title":"J Proteome Res"},{"issue":"2","key":"9262_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ab.2010.10.027","volume":"409","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Chi square comparison of tryptic peptide-to-protein distributions of tandem mass spectrometry from blood with those of random expectation. Anal Biochem. 2011;409(2):189\u201394.","journal-title":"Anal Biochem"},{"key":"9262_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ab.2010.12.003","volume":"411","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Peptide-to-protein distribution versus a competition for significance to estimate error rate in blood protein identification. Anal Biochem. 2011;411:241\u201353.","journal-title":"Anal Biochem"},{"issue":"9","key":"9262_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/bth092","volume":"20","author":"R Craig","year":"2004","unstructured":"Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics. 2004;20(9):1466\u20137.","journal-title":"Bioinformatics"},{"issue":"1","key":"9262_CR36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling false discovery rate: a practical approach to multiple testing. J Roy Stat Soc. 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc"},{"key":"9262_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12014-018-9211-3","volume":"15","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. The plasma peptidome. Clin Proteomics. 2018;15:39.","journal-title":"Clin Proteomics"},{"key":"9262_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ab.2016.07.021","volume":"513","author":"JC Howard","year":"2016","unstructured":"Howard JC, et al. OxLDL receptor chromatography from live human U937 cells identifies SYK(L) that regulates phagocytosis of oxLDL. Anal Biochem. 2016;513:7\u201320.","journal-title":"Anal Biochem"},{"key":"9262_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12014-018-9215-z","volume":"15","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. The plasma peptides of ovarian cancer. Clin Proteomics. 2018;15:41.","journal-title":"Clin Proteomics"},{"issue":"1","key":"9262_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ctrv.2013.06.006","volume":"40","author":"SW Lam","year":"2014","unstructured":"Lam SW, Jimenez CR, Boven E. Breast cancer classification by proteomic technologies: current state of knowledge. Cancer Treat Rev. 2014;40(1):129\u201338.","journal-title":"Cancer Treat Rev"},{"issue":"27","key":"9262_CR41","doi-asserted-by":"crossref","first-page":"41346","DOI":"10.18632\/oncotarget.9325","volume":"7","author":"HG Zhang","year":"2016","unstructured":"Zhang HG, et al. Isolation, identification, and characterization of novel nanovesicles. Oncotarget. 2016;7(27):41346\u201362.","journal-title":"Oncotarget"},{"issue":"4","key":"9262_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1242\/jcs.190835","volume":"130","author":"J Diaz-Vera","year":"2017","unstructured":"Diaz-Vera J, et al. A proteomic approach to identify endosomal cargoes controlling cancer invasiveness. J Cell Sci. 2017;130(4):697\u2013711.","journal-title":"J Cell Sci"},{"issue":"10","key":"9262_CR43","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1021\/pr300606e","volume":"11","author":"SA Whelan","year":"2012","unstructured":"Whelan SA, et al. Mass spectrometry (LC\u2013MS\/MS) identified proteomic biosignatures of breast cancer in proximal fluid. J Proteome Res. 2012;11(10):5034\u201345.","journal-title":"J Proteome Res"},{"issue":"4","key":"9262_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1074\/mcp.M400009-MCP200","volume":"3","author":"JE Celis","year":"2004","unstructured":"Celis JE, et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics. 2004;3(4):327\u201344.","journal-title":"Mol Cell Proteomics"},{"issue":"28","key":"9262_CR45","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1016\/j.chroma.2009.05.030","volume":"1216","author":"L Hu","year":"2009","unstructured":"Hu L, et al. Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. J Chromatogr A. 2009;1216(28):5377\u201384.","journal-title":"J Chromatogr A"},{"issue":"4","key":"9262_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/omi.2009.0016","volume":"13","author":"X Hu","year":"2009","unstructured":"Hu X, et al. Comparative serum proteome analysis of human lymph node negative\/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology. OMICS. 2009;13(4):291\u2013300.","journal-title":"OMICS"},{"issue":"10","key":"9262_CR47","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1373\/clinchem.2005.065862","volume":"52","author":"Z Yang","year":"2006","unstructured":"Yang Z, et al. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin Chem. 2006;52(10):1897\u2013905.","journal-title":"Clin Chem"},{"issue":"1","key":"9262_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/pmic.200300495","volume":"4","author":"R Zhang","year":"2004","unstructured":"Zhang R, et al. Mining biomarkers in human sera using proteomic tools. Proteomics. 2004;4(1):244\u201356.","journal-title":"Proteomics"},{"issue":"8","key":"9262_CR49","first-page":"2904","volume":"9","author":"B Ye","year":"2003","unstructured":"Ye B, et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003;9(8):2904\u201311.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9262_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1559-0275-11-3","volume":"11","author":"J Marshall","year":"2014","unstructured":"Marshall J, et al. Creation of a federated database of blood proteins: a powerful new tool for finding and characterizing biomarkers in serum. Clin Proteomics. 2014;11(1):3.","journal-title":"Clin Proteomics"},{"issue":"3","key":"9262_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbrc.2008.11.050","volume":"378","author":"C Looze","year":"2008","unstructured":"Looze C, et al. Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun. 2008;378(3):433\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7559","key":"9262_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","volume":"523","author":"SA Melo","year":"2015","unstructured":"Melo SA, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177\u201382.","journal-title":"Nature"},{"issue":"1","key":"9262_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1559-0275-11-13","volume":"11","author":"A Bery","year":"2014","unstructured":"Bery A, et al. Deciphering the ovarian cancer ascites fluid peptidome. Clin Proteomics. 2014;11(1):13.","journal-title":"Clin Proteomics"},{"key":"9262_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jprot.2014.03.018","volume":"103","author":"GS Karagiannis","year":"2014","unstructured":"Karagiannis GS, et al. In-depth proteomic delineation of the colorectal cancer exoproteome: mechanistic insight and identification of potential biomarkers. J Proteomics. 2014;103:121\u201336.","journal-title":"J Proteomics"},{"issue":"4","key":"9262_CR55","first-page":"429","volume":"16","author":"OV Krokhin","year":"2005","unstructured":"Krokhin OV, Ens W, Standing KG. MALDI QqTOF MS combined with off-line HPLC for characterization of protein primary structure and post-translational modifications. J Biomol Tech. 2005;16(4):429\u201340.","journal-title":"J Biomol Tech"},{"issue":"6","key":"9262_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1044-0305(02)00384-7","volume":"13","author":"JC Schwartz","year":"2002","unstructured":"Schwartz JC, Senko MW, Syka JE. A two-dimensional quadrupole ion trap mass spectrometer. J Am Soc Mass Spectrom. 2002;13(6):659\u201369.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"8","key":"9262_CR57","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1021\/ac00104a020","volume":"67","author":"JR Yates 3rd","year":"1995","unstructured":"Yates JR 3rd, et al. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem. 1995;67(8):1426\u201336.","journal-title":"Anal Chem"},{"key":"9262_CR58","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jprot.2010.02.007","volume":"73","author":"P Bowden","year":"2010","unstructured":"Bowden P, et al. Meta sequence analysis of human blood peptides and their parent proteins. J Proteomics. 2010;73:1163\u201375.","journal-title":"J Proteomics"},{"issue":"7","key":"9262_CR59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nbt.3267","volume":"33","author":"JM Chick","year":"2015","unstructured":"Chick JM, et al. A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat Biotechnol. 2015;33(7):743\u20139.","journal-title":"Nat Biotechnol"},{"key":"9262_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jprot.2016.07.033","volume":"148","author":"S Suman","year":"2016","unstructured":"Suman S, et al. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. J Proteomics. 2016;148:183\u201393.","journal-title":"J Proteomics"},{"issue":"5\u20136","key":"9262_CR61","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jchromb.2010.01.011","volume":"878","author":"I van den Broek","year":"2010","unstructured":"van den Broek I, et al. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(5\u20136):590\u2013602.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"9262_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, et al. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310.","journal-title":"J Mol Biol"},{"issue":"3","key":"9262_CR63","doi-asserted-by":"publisher","first-page":"e0174126","DOI":"10.1371\/journal.pone.0174126","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee J, et al. Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism. PLoS ONE. 2017;12(3):e0174126.","journal-title":"PLoS ONE"},{"issue":"12","key":"9262_CR64","first-page":"16046","volume":"8","author":"B Cao","year":"2015","unstructured":"Cao B, et al. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(12):16046\u201354.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"9262_CR65","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1042\/CS20150451","volume":"129","author":"GL Semenza","year":"2015","unstructured":"Semenza GL. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors. Clin Sci (Lond). 2015;129(12):1037\u201345.","journal-title":"Clin Sci (Lond)"},{"issue":"51","key":"9262_CR66","doi-asserted-by":"publisher","first-page":"e13551","DOI":"10.1097\/MD.0000000000013551","volume":"97","author":"C Nie","year":"2018","unstructured":"Nie C, et al. Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer. Medicine (Baltimore). 2018;97(51):e13551.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"9262_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cancergen.2014.02.001","volume":"207","author":"OM Akay","year":"2014","unstructured":"Akay OM, et al. BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. Cancer Genet. 2014;207(3):87\u201393.","journal-title":"Cancer Genet"},{"issue":"Suppl 1","key":"9262_CR68","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1517\/13543781003701011","volume":"19","author":"CC Yiu","year":"2010","unstructured":"Yiu CC, et al. Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance. Expert Opin Investig Drugs. 2010;19(Suppl 1):S79\u201389.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"9262_CR69","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1038\/s41467-018-06003-9","volume":"9","author":"MC Klein","year":"2018","unstructured":"Klein MC, et al. AXER is an ATP\/ADP exchanger in the membrane of the endoplasmic reticulum. Nat Commun. 2018;9(1):3489.","journal-title":"Nat Commun"},{"issue":"5","key":"9262_CR70","first-page":"460","volume":"27","author":"WJ Liang","year":"2008","unstructured":"Liang WJ, et al. Differentially expressed genes between upward and downward progressing types of nasopharyngeal carcinoma. Ai Zheng. 2008;27(5):460\u20135.","journal-title":"Ai Zheng"},{"issue":"5","key":"9262_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/tpj.2012.24","volume":"13","author":"JY Han","year":"2013","unstructured":"Han JY, et al. A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer. Pharmacogenomics J. 2013;13(5):417\u201322.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"9262_CR72","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3892\/ijo.2016.3615","volume":"49","author":"NB Sulaiman","year":"2016","unstructured":"Sulaiman NB, et al. An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2\/STAT3 signaling pathway. Int J Oncol. 2016;49(3):1221\u20139.","journal-title":"Int J Oncol"},{"issue":"14","key":"9262_CR73","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1158\/0008-5472.CAN-12-4078","volume":"73","author":"K Wu","year":"2013","unstructured":"Wu K, et al. EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1. Cancer Res. 2013;73(14):4488\u201399.","journal-title":"Cancer Res"},{"issue":"21","key":"9262_CR74","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1073\/pnas.97.21.11451","volume":"97","author":"S Chaudhuri","year":"2000","unstructured":"Chaudhuri S, et al. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci USA. 2000;97(21):11451\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"9262_CR75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/mc.22128","volume":"54","author":"Y He","year":"2015","unstructured":"He Y, et al. Potentially functional polymorphisms in aminoacyl-tRNA synthetases genes are associated with breast cancer risk in a Chinese population. Mol Carcinog. 2015;54(7):577\u201383.","journal-title":"Mol Carcinog"},{"issue":"18","key":"9262_CR76","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1074\/jbc.M109.061127","volume":"285","author":"SK Kwon","year":"2010","unstructured":"Kwon SK, et al. Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation. J Biol Chem. 2010;285(18):13966\u201378.","journal-title":"J Biol Chem"},{"issue":"4","key":"9262_CR77","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nm.2645","volume":"18","author":"N Aceto","year":"2012","unstructured":"Aceto N, et al. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat Med. 2012;18(4):529\u201337.","journal-title":"Nat Med"},{"issue":"7","key":"9262_CR78","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/2211-5463.12659","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, et al. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome. FEBS Open Bio. 2019;9(7):1270\u201380.","journal-title":"FEBS Open Bio"},{"issue":"22","key":"9262_CR79","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1002\/pmic.201200103","volume":"12","author":"D Kanojia","year":"2012","unstructured":"Kanojia D, et al. Proteomic profiling of cancer stem cells derived from primary tumors of HER2\/Neu transgenic mice. Proteomics. 2012;12(22):3407\u201315.","journal-title":"Proteomics"},{"issue":"9","key":"9262_CR80","doi-asserted-by":"publisher","first-page":"e43721","DOI":"10.1371\/journal.pone.0043721","volume":"7","author":"R Beheshti Zavareh","year":"2012","unstructured":"Beheshti Zavareh R, et al. Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS ONE. 2012;7(9):e43721.","journal-title":"PLoS ONE"},{"issue":"5","key":"9262_CR81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.0906-6705.2005.00278.x","volume":"14","author":"AJ Mamelak","year":"2005","unstructured":"Mamelak AJ, et al. Downregulation of NDUFA1 and other oxidative phosphorylation-related genes is a consistent feature of basal cell carcinoma. Exp Dermatol. 2005;14(5):336\u201348.","journal-title":"Exp Dermatol"},{"issue":"2","key":"9262_CR82","first-page":"241","volume":"19","author":"C Chi","year":"2015","unstructured":"Chi C, et al. RTN4\/Nogo is an independent prognostic marker for gastric cancer: preliminary results. Eur Rev Med Pharmacol Sci. 2015;19(2):241\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"13","key":"9262_CR83","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1158\/1078-0432.CCR-15-1709","volume":"22","author":"R Morita","year":"2016","unstructured":"Morita R, et al. Olfactory receptor family 7 subfamily C member 1 Is a novel marker of colon cancer-initiating cells and is a potent target of immunotherapy. Clin Cancer Res. 2016;22(13):3298\u2013309.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9262_CR84","doi-asserted-by":"publisher","first-page":"15399","DOI":"10.1038\/s41598-018-33677-4","volume":"8","author":"A Adamus","year":"2018","unstructured":"Adamus A, et al. GCSH antisense regulation determines breast cancer cells\u2019 viability. Sci Rep. 2018;8(1):15399.","journal-title":"Sci Rep"},{"issue":"2","key":"9262_CR85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccr.2013.06.004","volume":"24","author":"M Masiero","year":"2013","unstructured":"Masiero M, et al. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. Cancer Cell. 2013;24(2):229\u201341.","journal-title":"Cancer Cell"},{"issue":"4","key":"9262_CR86","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.18632\/oncotarget.14286","volume":"8","author":"WX Li","year":"2017","unstructured":"Li WX, et al. Comprehensive tissue-specific gene set enrichment analysis and transcription factor analysis of breast cancer by integrating 14 gene expression datasets. Oncotarget. 2017;8(4):6775\u201386.","journal-title":"Oncotarget"},{"issue":"27","key":"9262_CR87","doi-asserted-by":"publisher","first-page":"42661","DOI":"10.18632\/oncotarget.7410","volume":"7","author":"E Garattini","year":"2016","unstructured":"Garattini E, et al. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer. Oncotarget. 2016;7(27):42661\u201382.","journal-title":"Oncotarget"},{"issue":"3","key":"9262_CR88","doi-asserted-by":"publisher","first-page":"e1445941","DOI":"10.1080\/23723556.2018.1445941","volume":"5","author":"H Guo","year":"2018","unstructured":"Guo H, Sadoul R, Gibbings D. Autophagy-independent effects of autophagy-related-5 (Atg5) on exosome production and metastasis. Mol Cell Oncol. 2018;5(3):e1445941.","journal-title":"Mol Cell Oncol"},{"issue":"8","key":"9262_CR89","doi-asserted-by":"publisher","first-page":"e1800148","DOI":"10.1002\/pmic.201800148","volume":"19","author":"A Rai","year":"2019","unstructured":"Rai A, et al. Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics. 2019;19(8):e1800148.","journal-title":"Proteomics"},{"issue":"10","key":"9262_CR90","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/onc.2014.64","volume":"34","author":"Z Liu","year":"2015","unstructured":"Liu Z, et al. PDZ and LIM domain protein 1(PDLIM1)\/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with alpha-actinin. Oncogene. 2015;34(10):1300\u201311.","journal-title":"Oncogene"},{"key":"9262_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13148-015-0089-x","volume":"7","author":"RP Pangeni","year":"2015","unstructured":"Pangeni RP, et al. The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain. Clin Epigenetics. 2015;7:57.","journal-title":"Clin Epigenetics"},{"issue":"45","key":"9262_CR92","doi-asserted-by":"publisher","first-page":"31373","DOI":"10.1074\/jbc.M114.579839","volume":"289","author":"J Qi","year":"2014","unstructured":"Qi J, et al. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor alpha gene through GATA-binding protein 3 (GATA3). J Biol Chem. 2014;289(45):31373\u201381.","journal-title":"J Biol Chem"},{"issue":"11","key":"9262_CR93","doi-asserted-by":"publisher","first-page":"E1307","DOI":"10.1073\/pnas.1500536112","volume":"112","author":"SP Selvanathan","year":"2015","unstructured":"Selvanathan SP, et al. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proc Natl Acad Sci USA. 2015;112(11):E1307\u201316.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"9262_CR94","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/tpj.2015.73","volume":"16","author":"E Rumiato","year":"2016","unstructured":"Rumiato E, et al. Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study. Pharmacogenomics J. 2016;16(6):525\u20139.","journal-title":"Pharmacogenomics J"},{"issue":"20","key":"9262_CR95","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1002\/cncr.29465","volume":"121","author":"TY Cheng","year":"2015","unstructured":"Cheng TY, et al. Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: women\u2019s Health Initiative Observational Study. Cancer. 2015;121(20):3684\u201391.","journal-title":"Cancer"},{"issue":"3","key":"9262_CR96","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41419-019-1475-7","volume":"10","author":"M Peng","year":"2019","unstructured":"Peng M, et al. Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis. Cell Death Dis. 2019;10(3):228.","journal-title":"Cell Death Dis"},{"issue":"11","key":"9262_CR97","doi-asserted-by":"publisher","first-page":"e0187194","DOI":"10.1371\/journal.pone.0187194","volume":"12","author":"N Bibens-Laulan","year":"2017","unstructured":"Bibens-Laulan N, St-Pierre Y. Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7. PLoS ONE. 2017;12(11):e0187194.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"9262_CR98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-006-9350-0","volume":"298","author":"R Gornati","year":"2007","unstructured":"Gornati R, et al. Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR. Mol Cell Biochem. 2007;298(1\u20132):59\u201368.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"9262_CR99","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1389200218666171101124931","volume":"19","author":"JE Megias-Vericat","year":"2018","unstructured":"Megias-Vericat JE, et al. Pharmacogenetics of metabolic genes of anthracyclines in acute myeloid leukemia. Curr Drug Metab. 2018;19(1):55\u201374.","journal-title":"Curr Drug Metab"},{"issue":"13","key":"9262_CR100","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/MCB.00104-14","volume":"34","author":"Y Sun","year":"2014","unstructured":"Sun Y, Li X. The canonical wnt signal restricts the glycogen synthase kinase 3\/fbw7-dependent ubiquitination and degradation of eya1 phosphatase. Mol Cell Biol. 2014;34(13):2409\u201317.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9262_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jcp.24698","volume":"230","author":"P Garrido","year":"2015","unstructured":"Garrido P, et al. Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. J Cell Physiol. 2015;230(1):191\u20138.","journal-title":"J Cell Physiol"},{"issue":"10","key":"9262_CR102","doi-asserted-by":"publisher","first-page":"e0185565","DOI":"10.1371\/journal.pone.0185565","volume":"12","author":"F Xie","year":"2017","unstructured":"Xie F, et al. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. PLoS ONE. 2017;12(10):e0185565.","journal-title":"PLoS ONE"},{"key":"9262_CR103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jim.2017.09.011","volume":"452","author":"WS Wu","year":"2018","unstructured":"Wu WS, et al. Human CCDC47 sandwich immunoassay development with electrochemiluminescence technology. J Immunol Methods. 2018;452:12\u20139.","journal-title":"J Immunol Methods"},{"issue":"2","key":"9262_CR104","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr3644","volume":"16","author":"S Tan","year":"2014","unstructured":"Tan S, et al. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res. 2014;16(2):R40.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"9262_CR105","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1074\/jbc.M310591200","volume":"279","author":"HJ Lee","year":"2004","unstructured":"Lee HJ, et al. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes. J Biol Chem. 2004;279(4):2666\u201372.","journal-title":"J Biol Chem"},{"issue":"14","key":"9262_CR106","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1158\/0008-5472.CAN-06-3234","volume":"67","author":"Y Li","year":"2007","unstructured":"Li Y, et al. Cancer cells and normal cells differ in their requirements for Thoc1. Cancer Res. 2007;67(14):6657\u201364.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"9262_CR107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbrc.2015.10.166","volume":"468","author":"C Liu","year":"2015","unstructured":"Liu C, et al. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer. Biochem Biophys Res Commun. 2015;468(1\u20132):53\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"9262_CR108","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/blood-2009-03-212969","volume":"114","author":"VG Oehler","year":"2009","unstructured":"Oehler VG, et al. The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. Blood. 2009;114(15):3292\u20138.","journal-title":"Blood"},{"issue":"5","key":"9262_CR109","doi-asserted-by":"publisher","first-page":"e0155660","DOI":"10.1371\/journal.pone.0155660","volume":"11","author":"WC Chen","year":"2016","unstructured":"Chen WC, et al. Systematic analysis of gene expression alterations and clinical outcomes for long-chain acyl-coenzyme a synthetase family in cancer. PLoS ONE. 2016;11(5):e0155660.","journal-title":"PLoS ONE"},{"issue":"20","key":"9262_CR110","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.1158\/1078-0432.CCR-04-0548","volume":"11","author":"MA Folgueira","year":"2005","unstructured":"Folgueira MA, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res. 2005;11(20):7434\u201343.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9262_CR111","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nsmb.1915","volume":"17","author":"R Buisson","year":"2010","unstructured":"Buisson R, et al. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nat Struct Mol Biol. 2010;17(10):1247\u201354.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"9262_CR112","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/carcin\/bgu044","volume":"35","author":"K Kim","year":"2014","unstructured":"Kim K, et al. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation. Carcinogenesis. 2014;35(6):1352\u201361.","journal-title":"Carcinogenesis"},{"issue":"4","key":"9262_CR113","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1172\/JCI74440","volume":"125","author":"W van Roosmalen","year":"2015","unstructured":"van Roosmalen W, et al. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. J Clin Invest. 2015;125(4):1648\u201364.","journal-title":"J Clin Invest"},{"issue":"4","key":"9262_CR114","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbrc.2006.09.136","volume":"350","author":"DA Kwasnicka-Crawford","year":"2006","unstructured":"Kwasnicka-Crawford DA, Carson AR, Scherer SW. IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. Biochem Biophys Res Commun. 2006;350(4):890\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9262_CR115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-010-0825-z","volume":"125","author":"H Chang","year":"2011","unstructured":"Chang H, et al. Identification of genes associated with chemosensitivity to SAHA\/taxane combination treatment in taxane-resistant breast cancer cells. Breast Cancer Res Treat. 2011;125(1):55\u201363.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9262_CR116","doi-asserted-by":"publisher","first-page":"e1003419","DOI":"10.1371\/journal.pgen.1003419","volume":"9","author":"CA Haiman","year":"2013","unstructured":"Haiman CA, et al. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. PLoS Genet. 2013;9(3):e1003419.","journal-title":"PLoS Genet"},{"issue":"3","key":"9262_CR117","first-page":"457","volume":"17","author":"RR Mewani","year":"2006","unstructured":"Mewani RR, et al. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells. Int J Mol Med. 2006;17(3):457\u201363.","journal-title":"Int J Mol Med"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-019-9262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12014-019-9262-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-019-9262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T21:39:28Z","timestamp":1722202768000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-019-9262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9262"],"URL":"https:\/\/doi.org\/10.1186\/s12014-019-9262-0","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human EDTA plasma samples were obtained under Ryerson Ethical Reviews Board Protocol REB 2015-207.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No original figures or tables from any other publisher was reproduced in this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}